MD1L1_HUMAN - dbPTM
MD1L1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MD1L1_HUMAN
UniProt AC Q9Y6D9
Protein Name Mitotic spindle assembly checkpoint protein MAD1
Gene Name MAD1L1
Organism Homo sapiens (Human).
Sequence Length 718
Subcellular Localization Nucleus. Chromosome, centromere, kinetochore . Nucleus envelope . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole . Detected at the nucleus envelope during in
Protein Description Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. May recruit MAD2L1 to unattached kinetochores. Has a role in the correct positioning of the septum. Required for anchoring MAD2L1 to the nuclear periphery. Binds to the TERT promoter and represses telomerase expression, possibly by interfering with MYC binding..
Protein Sequence MEDLGENTMVLSTLRSLNNFISQRVEGGSGLDISTSAPGSLQMQYQQSMQLEERAEQIRSKSHLIQVEREKMQMELSHKRARVELERAASTSARNYEREVDRNQELLTRIRQLQEREAGAEEKMQEQLERNRQCQQNLDAASKRLREKEDSLAQAGETINALKGRISELQWSVMDQEMRVKRLESEKQELQEQLDLQHKKCQEANQKIQELQASQEARADHEQQIKDLEQKLSLQEQDAAIVKNMKSELVRLPRLERELKQLREESAHLREMRETNGLLQEELEGLQRKLGRQEKMQETLVGLELENERLLAKLQSWERLDQTMGLSIRTPEDLSRFVVELQQRELALKDKNSAVTSSARGLEKARQQLQEELRQVSGQLLEERKKRETHEALARRLQKRVLLLTKERDGMRAILGSYDSELTPAEYSPQLTRRMREAEDMVQKVHSHSAEMEAQLSQALEELGGQKQRADMLEMELKMLKSQSSSAEQSFLFSREEADTLRLKVEELEGERSRLEEEKRMLEAQLERRALQGDYDQSRTKVLHMSLNPTSVARQRLREDHSQLQAECERLRGLLRAMERGGTVPADLEAAAASLPSSKEVAELKKQVESAELKNQRLKEVFQTKIQEFRKACYTLTGYQIDITTENQYRLTSLYAEHPGDCLIFKATSPSGSKMQLLETEFSHTVGELIEVHLRRQDSIPAFLSSLTLELFSRQTVA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEDLGENT
-------CCCCHHHH
9.0222223895
8PhosphorylationMEDLGENTMVLSTLR
CCCCHHHHHHHHHHH
12.3520068231
12PhosphorylationGENTMVLSTLRSLNN
HHHHHHHHHHHHHHH
17.6222199227
13PhosphorylationENTMVLSTLRSLNNF
HHHHHHHHHHHHHHH
23.2522199227
16PhosphorylationMVLSTLRSLNNFISQ
HHHHHHHHHHHHHHH
38.2625159151
22PhosphorylationRSLNNFISQRVEGGS
HHHHHHHHHCCCCCC
14.0624043423
29PhosphorylationSQRVEGGSGLDISTS
HHCCCCCCCCCCCCC
47.2218922800
55UbiquitinationSMQLEERAEQIRSKS
HHHHHHHHHHHHCCH
19.1429967540
61AcetylationRAEQIRSKSHLIQVE
HHHHHHCCHHHHHHH
31.8519608861
61SumoylationRAEQIRSKSHLIQVE
HHHHHHCCHHHHHHH
31.85-
61UbiquitinationRAEQIRSKSHLIQVE
HHHHHHCCHHHHHHH
31.8519608861
61SumoylationRAEQIRSKSHLIQVE
HHHHHHCCHHHHHHH
31.8528112733
62PhosphorylationAEQIRSKSHLIQVER
HHHHHCCHHHHHHHH
25.4428555341
68UbiquitinationKSHLIQVEREKMQME
CHHHHHHHHHHHHHH
38.4523000965
70UbiquitinationHLIQVEREKMQMELS
HHHHHHHHHHHHHHH
39.1029967540
71UbiquitinationLIQVEREKMQMELSH
HHHHHHHHHHHHHHH
40.4223000965
75UbiquitinationEREKMQMELSHKRAR
HHHHHHHHHHHHHHH
30.1729967540
76UbiquitinationREKMQMELSHKRARV
HHHHHHHHHHHHHHH
5.6524816145
77PhosphorylationEKMQMELSHKRARVE
HHHHHHHHHHHHHHH
17.4125159151
79UbiquitinationMQMELSHKRARVELE
HHHHHHHHHHHHHHH
44.3629967540
792-HydroxyisobutyrylationMQMELSHKRARVELE
HHHHHHHHHHHHHHH
44.36-
81UbiquitinationMELSHKRARVELERA
HHHHHHHHHHHHHHH
25.3621890473
90PhosphorylationVELERAASTSARNYE
HHHHHHHHHCCHHHH
23.1622067460
91PhosphorylationELERAASTSARNYER
HHHHHHHHCCHHHHH
22.9822461510
92PhosphorylationLERAASTSARNYERE
HHHHHHHCCHHHHHH
23.8022067460
94UbiquitinationRAASTSARNYEREVD
HHHHHCCHHHHHHHH
46.1324816145
96PhosphorylationASTSARNYEREVDRN
HHHCCHHHHHHHHHH
15.7122461510
115UbiquitinationTRIRQLQEREAGAEE
HHHHHHHHHHHCHHH
62.1729967540
123UbiquitinationREAGAEEKMQEQLER
HHHCHHHHHHHHHHH
37.0724816145
139UbiquitinationRQCQQNLDAASKRLR
HHHHHHHHHHHHHHH
47.8729967540
142PhosphorylationQQNLDAASKRLREKE
HHHHHHHHHHHHHHH
21.7424260401
143AcetylationQNLDAASKRLREKED
HHHHHHHHHHHHHHH
51.2125953088
143UbiquitinationQNLDAASKRLREKED
HHHHHHHHHHHHHHH
51.2129967540
1432-HydroxyisobutyrylationQNLDAASKRLREKED
HHHHHHHHHHHHHHH
51.21-
148UbiquitinationASKRLREKEDSLAQA
HHHHHHHHHHHHHHH
61.4629967540
156UbiquitinationEDSLAQAGETINALK
HHHHHHHHHHHHHHH
22.0923000965
159UbiquitinationLAQAGETINALKGRI
HHHHHHHHHHHHHHH
2.1823000965
163UbiquitinationGETINALKGRISELQ
HHHHHHHHHHHHHHH
43.6729967540
172PhosphorylationRISELQWSVMDQEMR
HHHHHHHHHHCHHHH
8.4626074081
182UbiquitinationDQEMRVKRLESEKQE
CHHHHHHHHHHHHHH
40.6124816145
185PhosphorylationMRVKRLESEKQELQE
HHHHHHHHHHHHHHH
55.4726074081
187UbiquitinationVKRLESEKQELQEQL
HHHHHHHHHHHHHHH
59.3524816145
207UbiquitinationKCQEANQKIQELQAS
HHHHHHHHHHHHHHH
46.2829967540
214PhosphorylationKIQELQASQEARADH
HHHHHHHHHHHHHHH
18.6517525332
215UbiquitinationIQELQASQEARADHE
HHHHHHHHHHHHHHH
51.9221890473
221UbiquitinationSQEARADHEQQIKDL
HHHHHHHHHHHHHHH
33.5129967540
221UbiquitinationSQEARADHEQQIKDL
HHHHHHHHHHHHHHH
33.51-
231UbiquitinationQIKDLEQKLSLQEQD
HHHHHHHHHCHHHHH
30.5729967540
233PhosphorylationKDLEQKLSLQEQDAA
HHHHHHHCHHHHHHH
34.7328555341
259UbiquitinationLPRLERELKQLREES
HHHHHHHHHHHHHHH
5.5424816145
266PhosphorylationLKQLREESAHLREMR
HHHHHHHHHHHHHHH
19.0827174698
303UbiquitinationMQETLVGLELENERL
HHHHHHCHHHHCHHH
5.4621890473
304UbiquitinationQETLVGLELENERLL
HHHHHCHHHHCHHHH
48.3824816145
313UbiquitinationENERLLAKLQSWERL
HCHHHHHHHHHHHHH
47.2129967540
314UbiquitinationNERLLAKLQSWERLD
CHHHHHHHHHHHHHH
3.9723000965
323PhosphorylationSWERLDQTMGLSIRT
HHHHHHHHCCCCCCC
16.9320068231
324SulfoxidationWERLDQTMGLSIRTP
HHHHHHHCCCCCCCH
4.1721406390
327PhosphorylationLDQTMGLSIRTPEDL
HHHHCCCCCCCHHHH
12.3220068231
336PhosphorylationRTPEDLSRFVVELQQ
CCHHHHHHHHHHHHH
35.3632142685
351UbiquitinationRELALKDKNSAVTSS
HHHHHCCCCCHHHHH
51.7424816145
358PhosphorylationKNSAVTSSARGLEKA
CCCHHHHHHHHHHHH
16.7826546556
359UbiquitinationNSAVTSSARGLEKAR
CCHHHHHHHHHHHHH
14.8823000965
375UbiquitinationQLQEELRQVSGQLLE
HHHHHHHHHHHHHHH
46.4829967540
377PhosphorylationQEELRQVSGQLLEER
HHHHHHHHHHHHHHH
16.69-
386UbiquitinationQLLEERKKRETHEAL
HHHHHHHHHHHHHHH
62.7823000965
389UbiquitinationEERKKRETHEALARR
HHHHHHHHHHHHHHH
29.1123000965
389UbiquitinationEERKKRETHEALARR
HHHHHHHHHHHHHHH
29.11-
406UbiquitinationKRVLLLTKERDGMRA
HHHHHHCCCCCCHHH
51.2023000965
4062-HydroxyisobutyrylationKRVLLLTKERDGMRA
HHHHHHCCCCCCHHH
51.20-
412UbiquitinationTKERDGMRAILGSYD
CCCCCCHHHHHCCCC
24.8124816145
412UbiquitinationTKERDGMRAILGSYD
CCCCCCHHHHHCCCC
24.81-
415UbiquitinationRDGMRAILGSYDSEL
CCCHHHHHCCCCCCC
3.4924816145
417PhosphorylationGMRAILGSYDSELTP
CHHHHHCCCCCCCCH
23.4823403867
418PhosphorylationMRAILGSYDSELTPA
HHHHHCCCCCCCCHH
22.9930266825
420PhosphorylationAILGSYDSELTPAEY
HHHCCCCCCCCHHHC
26.6930266825
423PhosphorylationGSYDSELTPAEYSPQ
CCCCCCCCHHHCCHH
19.1930266825
427PhosphorylationSELTPAEYSPQLTRR
CCCCHHHCCHHHHHH
27.9730266825
428PhosphorylationELTPAEYSPQLTRRM
CCCHHHCCHHHHHHH
9.5525159151
431UbiquitinationPAEYSPQLTRRMREA
HHHCCHHHHHHHHHH
4.5823000965
432PhosphorylationAEYSPQLTRRMREAE
HHCCHHHHHHHHHHH
15.8130266825
434UbiquitinationYSPQLTRRMREAEDM
CCHHHHHHHHHHHHH
24.2323000965
447PhosphorylationDMVQKVHSHSAEMEA
HHHHHHHHCHHHHHH
23.3323401153
449PhosphorylationVQKVHSHSAEMEAQL
HHHHHHCHHHHHHHH
29.0123532336
457UbiquitinationAEMEAQLSQALEELG
HHHHHHHHHHHHHCC
11.0024816145
457PhosphorylationAEMEAQLSQALEELG
HHHHHHHHHHHHHCC
11.0023532336
459UbiquitinationMEAQLSQALEELGGQ
HHHHHHHHHHHCCCH
17.3623000965
462UbiquitinationQLSQALEELGGQKQR
HHHHHHHHCCCHHHH
54.2723000965
467UbiquitinationLEELGGQKQRADMLE
HHHCCCHHHHHHHHH
45.0529967540
470UbiquitinationLGGQKQRADMLEMEL
CCCHHHHHHHHHHHH
12.2223000965
478AcetylationDMLEMELKMLKSQSS
HHHHHHHHHHHCCCC
28.9624887495
478UbiquitinationDMLEMELKMLKSQSS
HHHHHHHHHHHCCCC
28.9623000965
481UbiquitinationEMELKMLKSQSSSAE
HHHHHHHHCCCCCHH
42.8423000965
482PhosphorylationMELKMLKSQSSSAEQ
HHHHHHHCCCCCHHH
31.1920068231
484PhosphorylationLKMLKSQSSSAEQSF
HHHHHCCCCCHHHHH
33.0920068231
485PhosphorylationKMLKSQSSSAEQSFL
HHHHCCCCCHHHHHH
26.4020068231
485UbiquitinationKMLKSQSSSAEQSFL
HHHHCCCCCHHHHHH
26.4024816145
486PhosphorylationMLKSQSSSAEQSFLF
HHHCCCCCHHHHHHH
40.8620068231
490PhosphorylationQSSSAEQSFLFSREE
CCCCHHHHHHHCHHH
18.5419691289
494PhosphorylationAEQSFLFSREEADTL
HHHHHHHCHHHHHHH
40.7119691289
500PhosphorylationFSREEADTLRLKVEE
HCHHHHHHHHHHHHH
22.33-
504UbiquitinationEADTLRLKVEELEGE
HHHHHHHHHHHHHCH
40.9624816145
507UbiquitinationTLRLKVEELEGERSR
HHHHHHHHHHCHHHH
55.9229967540
507UbiquitinationTLRLKVEELEGERSR
HHHHHHHHHHCHHHH
55.92-
513PhosphorylationEELEGERSRLEEEKR
HHHHCHHHHHHHHHH
36.5922496350
522UbiquitinationLEEEKRMLEAQLERR
HHHHHHHHHHHHHHH
5.9929967540
522UbiquitinationLEEEKRMLEAQLERR
HHHHHHHHHHHHHHH
5.99-
527UbiquitinationRMLEAQLERRALQGD
HHHHHHHHHHHHCCC
28.2129967540
533UbiquitinationLERRALQGDYDQSRT
HHHHHHCCCCCCCCC
35.9721890473
533UbiquitinationLERRALQGDYDQSRT
HHHHHHCCCCCCCCC
35.9721890473
535PhosphorylationRRALQGDYDQSRTKV
HHHHCCCCCCCCCEE
23.7827642862
538PhosphorylationLQGDYDQSRTKVLHM
HCCCCCCCCCEEEEE
38.7321815630
542UbiquitinationYDQSRTKVLHMSLNP
CCCCCCEEEEEECCH
4.3623000965
545UbiquitinationSRTKVLHMSLNPTSV
CCCEEEEEECCHHHH
4.2223000965
546PhosphorylationRTKVLHMSLNPTSVA
CCEEEEEECCHHHHH
17.7820068231
550PhosphorylationLHMSLNPTSVARQRL
EEEECCHHHHHHHHH
34.4620068231
551PhosphorylationHMSLNPTSVARQRLR
EEECCHHHHHHHHHH
18.2920068231
562PhosphorylationQRLREDHSQLQAECE
HHHHHCHHHHHHHHH
44.9328555341
568UbiquitinationHSQLQAECERLRGLL
HHHHHHHHHHHHHHH
4.0624816145
578UbiquitinationLRGLLRAMERGGTVP
HHHHHHHHHHCCCCC
2.6621890473
583PhosphorylationRAMERGGTVPADLEA
HHHHHCCCCCCCHHH
26.5820068231
594PhosphorylationDLEAAAASLPSSKEV
CHHHHHHCCCCHHHH
35.7720068231
597PhosphorylationAAAASLPSSKEVAEL
HHHHCCCCHHHHHHH
60.3720068231
598PhosphorylationAAASLPSSKEVAELK
HHHCCCCHHHHHHHH
30.7820068231
599UbiquitinationAASLPSSKEVAELKK
HHCCCCHHHHHHHHH
61.6229967540
606UbiquitinationKEVAELKKQVESAEL
HHHHHHHHHHHHHHH
72.6721890473
610PhosphorylationELKKQVESAELKNQR
HHHHHHHHHHHHHHH
28.3429162720
614UbiquitinationQVESAELKNQRLKEV
HHHHHHHHHHHHHHH
42.4129967540
614AcetylationQVESAELKNQRLKEV
HHHHHHHHHHHHHHH
42.4125953088
619UbiquitinationELKNQRLKEVFQTKI
HHHHHHHHHHHHHHH
54.7629967540
619MalonylationELKNQRLKEVFQTKI
HHHHHHHHHHHHHHH
54.7626320211
624PhosphorylationRLKEVFQTKIQEFRK
HHHHHHHHHHHHHHH
20.74-
625UbiquitinationLKEVFQTKIQEFRKA
HHHHHHHHHHHHHHH
31.4422817900
625AcetylationLKEVFQTKIQEFRKA
HHHHHHHHHHHHHHH
31.4425953088
634PhosphorylationQEFRKACYTLTGYQI
HHHHHHHHHHCCCEE
15.0529162720
649PhosphorylationDITTENQYRLTSLYA
EEECCCCEEEEEEEC
21.1218083107
666AcetylationPGDCLIFKATSPSGS
CCCEEEEEEECCCCC
43.7026051181
680PhosphorylationSKMQLLETEFSHTVG
CHHHHEHHHHHCHHH
42.1518922800
689UbiquitinationFSHTVGELIEVHLRR
HHCHHHHHHHHHHCC
3.1321890473
699PhosphorylationVHLRRQDSIPAFLSS
HHHCCCCCHHHHHHH
23.3318922800
708PhosphorylationPAFLSSLTLELFSRQ
HHHHHHHHHHHHHHC
21.8218922800
713PhosphorylationSLTLELFSRQTVA--
HHHHHHHHHCCCC--
35.7820068231
716PhosphorylationLELFSRQTVA-----
HHHHHHCCCC-----
19.7929162720

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
8TPhosphorylationKinaseTTKP33981
PSP
22SPhosphorylationKinasePLK1P53350
PSP
22SPhosphorylationKinaseTTKP33981
PSP
29SPhosphorylationKinasePLK1P53350
PSP
62SPhosphorylationKinaseTTKP33981
PSP
214SPhosphorylationKinaseATMQ13315
PSP
323TPhosphorylationKinaseTTKP33981
PSP
598SPhosphorylationKinaseTTKP33981
PSP
610SPhosphorylationKinaseTTKP33981
PSP
624TPhosphorylationKinaseTTKP33981
PSP
680TPhosphorylationKinasePLK1P53350
PSP
716TPhosphorylationKinaseTTKP33981
PSP
-KUbiquitinationE3 ubiquitin ligaseBIRC2Q13490
PMID:18082613

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MD1L1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MD1L1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TEX11_HUMANTEX11physical
16189514
NINL_HUMANNINLphysical
16189514
F131C_HUMANFAM131Cphysical
16189514
TRI29_HUMANTRIM29physical
16189514
AMOL2_HUMANAMOTL2physical
16189514
GCP4_HUMANTUBGCP4physical
16189514
MD1L1_HUMANMAD1L1physical
16189514
HDAC1_HUMANHDAC1physical
15388328
HDAC2_HUMANHDAC2physical
15388328
MD2L1_HUMANMAD2L1physical
11707408
MD2L1_HUMANMAD2L1physical
21525009
SIN3A_HUMANSIN3Aphysical
22783022
MD2L1_HUMANMAD2L1physical
21988832
ZZEF1_HUMANZZEF1physical
22863883
CDC20_HUMANCDC20physical
24581499
MD2L1_HUMANMAD2L1physical
24581499
MD2L1_HUMANMAD2L1physical
25012665
PCH2_HUMANTRIP13physical
25012665
RNF8_HUMANRNF8physical
25416956
BAG5_HUMANBAG5physical
25416956
SPAT2_HUMANSPATA2physical
25416956
UBP15_HUMANUSP15physical
25416956
NEBL_HUMANNEBLphysical
25416956
TRI29_HUMANTRIM29physical
25416956
LEGL_HUMANLGALSLphysical
25416956
CCHCR_HUMANCCHCR1physical
25416956
ZSC32_HUMANZSCAN32physical
25416956
CCD94_HUMANCCDC94physical
25416956
TSH3_HUMANTSHZ3physical
25416956
HAUS1_HUMANHAUS1physical
25416956
C19L2_HUMANCWF19L2physical
25416956
NUDC_HUMANNUDCphysical
26344197
STK24_HUMANSTK24physical
26344197
MD2L1_HUMANMAD2L1physical
18318601

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MD1L1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-61, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-428, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY.

TOP